BridgeBio Oncology Therapeutics Inc.

NASDAQ:BBOT

Biotechnology

Healthcare
$1.86 -0.39%

-$0.03 today

Market cap
$149.27M
Beta
0.29
P/E (TTM)
-1.5
EPS (TTM)
-$4.95
52W Low $7.00High $14.87

Volume 0.37M

Average 0.37M

Balance Sheet

Inspect the capital base behind the business.

Assets

$448.38M

FY 2025 · Annual

+130.6% YoY

Liabilities

$37.28M

FY 2025 · Annual

+553.3% YoY

Equity

$411.10M

FY 2025 · Annual

+117.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents0001.7M373.69M
Short-term Investments000051.77M
Net Receivables0000386K
Inventory00000
Other Current Assets0000(386K)
Total Current Assets0001.95M425.46M
Property, Plant & Equipment (Net)00000
Goodwill00000
Intangible Assets00000
Long-term Investments000192.45M132K
Tax Assets00000
Other Non-current Assets144.28K144.58K332.89K25.13K22.79M
Total Non-current Assets144.28K144.58K332.89K192.47M22.92M
Total Assets144.28K144.58K332.89K194.42M448.38M
Account Payables00001.37M
Short-term Debt36.96K43.11K70.1K00
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities00005.75M
Total Current Liabilities162.64K166.46K396.46K187.52K35.04M
Long-term Debt00002.24M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0005.52M0
Total Non-current Liabilities0005.52M2.24M
Total Liabilities162.64K166.46K396.46K5.71M37.29M
Common Stock288288460192.45M8K
Retained Earnings(43.36K)(46.88K)(88.57K)(3.73M)(356.57M)
Accumulated OCI000016K
Other Stockholders Equity0172000
Minority Interest00000
Total Equity(18.36K)(21.88K)(63.57K)188.72M411.1M
Total Debt36.96K43.11K70.1K02.77M
Net Debt36.96K43.11K70.1K(1.7M)(370.92M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$52.7M
Short-term Investments$199.6M
Receivables$146.0K
Other Current$14.1M
Total Current Assets$266.5M
PP&E (Net)$3.2M
Long-term Investments$136.7M
Other Non-current$11.2M
Total Non-current Assets$151.1M
Total Assets$417.6M

Analysis

Selected assets total $417.6M for Latest. The largest visible component is Short-term Investments at $199.6M, about 47.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 23, 2026

How much cash does BBOT have?

BridgeBio Oncology Therapeutics Inc. (BBOT) reported $373.69M in cash and equivalents in fiscal 2025.

How much debt does BBOT carry?

BridgeBio Oncology Therapeutics Inc. (BBOT) reported $2.77M of total debt, with net debt of -$370.92M.